Toxiplatin Injection 150 mg 1 Vialx15 mL

 1,892.00

Toxiplatin Injection contains Carboplatin | belongs to Alkylating agent

SKU: pg_22900_31704 Categories: ,

Alternate brands of Toxiplatin Injection 150 mg 1 Vialx15 mL

Brand Name Price Savings
Toxiplatin Injection 450 mg 1 Vialx45 mL  3,780.00 You will pay -1888 more
Pharmaplatin Injection 150 mg 1 Vialx20 mL  2,225.00 You will pay -333 more
Kemocarb Injection 450 mg 1 Vialx45 mL  4,450.00 You will pay -2558 more
Kemocarb Injection 150 mg 1 Vialx15 mL  2,225.00 You will pay -333 more
Cytocarb Injection 450 mg 1 Vialx45 mL  4,450.00 You will pay -2558 more
List of alternate brands

Reviews

There are no reviews yet.

Be the first to review “Toxiplatin Injection 150 mg 1 Vialx15 mL”

How it works

Toxiplatin Injection 150 mg 1 Vialx15 mL works by stopping the growth of cancer cells

Side effects

Major & minor side effects for Toxiplatin Injection 150 mg 1 Vialx15 mL

  • Pain at the injection site severe
  • Low WBC and Platelet count severe
  • Fever and chills severe
  • Difficult or painful urination severe
  • Skin rash severe
  • Unusual bleeding severe
  • Tingling or numbness of the hands and feet severe
  • Blurred vision severe
  • Ringing or buzzing in the ears severe
  • Nausea and Vomiting
  • Diarrhea
  • Loss of appetite

Uses of Toxiplatin Injection 150 mg 1 Vialx15 mL

What is it prescribed for?

  • Ovarian Cancer

    Toxiplatin Injection 150 mg 1 Vialx15 mL is used in the treatment of cancer that affects the ovaries.

Concerns

Frequently asked questions

  • Onset of action

    The peak effect of this medicine can be observed in 2 to 4 hours after intravenous injection.

  • Duration of Effect

    The effect of this medicine lasts for an average duration of 24 hours.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for pregnant women.

  • Usage while breast-feeding?

    This medicine is not recommended in breastfeeding women.

When not to use?

  • Allergy

    Not recommended in patients with known allergy to Toxiplatin Injection 150 mg 1 Vialx15 mL or other platinum-containing compounds.

  • Significant bleeding

    Not recommended in patients with the bleeding disorder.

  • Severe myelosuppression

    Not recommended in patients with low white blood cell and platelet count.

Warnings

Warnings for special population
  • Pregnancy

    This medicine may cause severe kidney injury. The risk may increase if taken with aminoglycoside antibiotics. Close monitoring of serum creatinine, urea, and sodium levels is necessary. Do not administer this medicine more than once every 3 to 4 weeks.

  • Breast-feeding

    This medicine is not recommended in breastfeeding women.

General Warnings
  • Impaired kidney function

    This medicine may cause severe kidney injury. The risk may increase if taken with aminoglycoside antibiotics. Close monitoring of serum creatinine, urea, and sodium levels is necessary. Do not administer this medicine more than once every 3 to 4 weeks.

  • Hearing impairment

    This medicine may cause the hearing problem which is more common in children. Audiometric testing should be performed before initiating the treatment and also before every dose. Any symptoms of the hearing problem should be reported to the doctor.

  • Allergy

    This medicine may cause serious skin reactions. Discontinue the treatment if any symptoms of allergy appear and do not restart.

  • Blood cell count

    This medicine may lower the white blood cells and platelets. Close monitoring of blood cell count is necessary. Do not start the treatment if the cell count is low.

  • Infections

    The chances of occurring infections are more in patients receiving this medicine. Hold the chemotherapy and start with the broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary.

Dosage

  • Missed Dose

    It is advised not to miss any dose. If you missed any dose, you should contact your doctor immediately.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Clozapine severe
  • Vancomycin moderate
  • Atorvastatin moderate
  • Live vaccines severe

General Instructions

This medicine is given in multiple cycles. It is important to receive the every scheduled dose and make a note of next scheduled dose. Close monitoring of blood cells counts and kidney function.

Other details

  • Usage does not depend on food timings
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information>

How to use Toxiplatin Injection 150 mg 1 Vialx15 mL

Administer as IV push or bolus over 15 min up to a continuous intravenous infusion over 24 hour. Reconstitute powder to yield a final conc of 10 mg/mL. May also be administered intraperitoneally. When administered as sequential infusions, taxane derivatives (docetaxel, paclitaxel) should be administered before platinum derivatives to limit myelosuppression and to enhance efficacy. Do not use needles or IV administration sets containing aluminium parts that may come in contact with carboplatin (aluminium can react causing precipitate formation and loss of potency).
Compatibility: Stable in D5¼ NS, D5½ NS, D5NS, D5W, NS.
Stability: Store at 25°C (77°F); excursions permitted from 15°C-30°C (59°F-86°F). Protect from light. Use carboplatin solutions within 8 hours of reconstitution or preparation when stored at room temperature (25°C; 77°F). When stored in the original multidose vial, the commercially available solution is stable for up to 14 days at room temperature even with multiple needle entries.

what are the adverse effects of Toxiplatin Injection 150 mg 1 Vialx15 mL?

GI disturbances, neurologic toxicity, myelosuppression, nephrotoxicity.

What happens if I miss a dose of Toxiplatin Injection 150 mg 1 Vialx15 mL?

Advanced Ovarian Carcinoma: Adults: Single Agent: 360 mg/m² IV on day 1, then every 4 wk. Combination Therapy: 300 mg/m² IV on 1, then every 4 wk x 6 cycles. Adjust based on platelet & neutrophil count.

One of the following licensed pharmacy from the nearest location will deliver Toxiplatin Injection 150 mg 1 Vialx15 mL. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Shopping Cart

Medicalstore.com.pk © All rights reserved

Made with ❤ by Dairah